Prescription drug giant GlaxoSmithKline agreed to pay a record $3 billion fine to settle a litany of charges stemming from the company's illegal promotion of its products. Among other criminal complaints, federal prosecutors had accused GlaxoSmithKline of promoting the anti-depression drug Paxil for children, even though the FDA had never approved Paxil for patients under 18. GlaxoSmithKline was also accused of bribing physicians to prescribe its products, part of a web of mutual back-scratching that critics say has compromised the prescription drug market.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- How I lost all my money
- Diagnosing the Home Alone burglars' injuries: A professional weighs in
- 43 TV shows to watch in 2014
- How academia's liberal bias is killing social science
- Why Pakistan won't hunt down the terrorists within its borders
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- 3 key insights about Obama from Chuck Todd's The Stranger
- George W. Bush 'ran the country like a cable network,' and other political insights from Chris Rock
- What would a U.S.-Russia war look like?
- How to make the ultimate grilled cheese
Subscribe to the Week